Copyright Reports & Markets. All rights reserved.

Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Isoniazid
      • 1.4.3 Rifampin (Rifadin, Rimactane)
      • 1.4.4 Ethambutol (Myambutol)
      • 1.4.5 Pyrazinamide
    • 1.5 Market by Application
      • 1.5.1 Global Tuberculosis (TB) Treatment Market Share by Application (2019-2025)
      • 1.5.2 Active TB
      • 1.5.3 Latent TB
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Tuberculosis (TB) Treatment Market Size
    • 2.2 Tuberculosis (TB) Treatment Growth Trends by Regions
      • 2.2.1 Tuberculosis (TB) Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Tuberculosis (TB) Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Tuberculosis (TB) Treatment Market Size by by Players
      • 3.1.1 Global Tuberculosis (TB) Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Tuberculosis (TB) Treatment Key Players Head office and Area Served
    • 3.3 Key Players Tuberculosis (TB) Treatment Product/Solution/Service
    • 3.4 Date of Enter into Tuberculosis (TB) Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Tuberculosis (TB) Treatment Market Size by Type (2014-2019)
    • 4.2 Global Tuberculosis (TB) Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 5.2 Tuberculosis (TB) Treatment Key Players in North America
    • 5.3 North America Tuberculosis (TB) Treatment Market Size by Type
    • 5.4 North America Tuberculosis (TB) Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 6.2 Tuberculosis (TB) Treatment Key Players in Europe
    • 6.3 Europe Tuberculosis (TB) Treatment Market Size by Type
    • 6.4 Europe Tuberculosis (TB) Treatment Market Size by Application

    7 China

    • 7.1 China Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 7.2 Tuberculosis (TB) Treatment Key Players in China
    • 7.3 China Tuberculosis (TB) Treatment Market Size by Type
    • 7.4 China Tuberculosis (TB) Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 8.2 Tuberculosis (TB) Treatment Key Players in Japan
    • 8.3 Japan Tuberculosis (TB) Treatment Market Size by Type
    • 8.4 Japan Tuberculosis (TB) Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 9.2 Tuberculosis (TB) Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Tuberculosis (TB) Treatment Market Size by Type
    • 9.4 Southeast Asia Tuberculosis (TB) Treatment Market Size by Application

    10 India

    • 10.1 India Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 10.2 Tuberculosis (TB) Treatment Key Players in India
    • 10.3 India Tuberculosis (TB) Treatment Market Size by Type
    • 10.4 India Tuberculosis (TB) Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Tuberculosis (TB) Treatment Market Size (2014-2019)
    • 11.2 Tuberculosis (TB) Treatment Key Players in Central & South America
    • 11.3 Central & South America Tuberculosis (TB) Treatment Market Size by Type
    • 11.4 Central & South America Tuberculosis (TB) Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Johnson & Johnson
      • 12.1.1 Johnson & Johnson Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Tuberculosis (TB) Treatment Introduction
      • 12.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2014-2019))
      • 12.1.5 Johnson & Johnson Recent Development
    • 12.2 Otsuka Pharmaceutical Co., Ltd
      • 12.2.1 Otsuka Pharmaceutical Co., Ltd Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Tuberculosis (TB) Treatment Introduction
      • 12.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.2.5 Otsuka Pharmaceutical Co., Ltd Recent Development
    • 12.3 Macleods Pharmaceutical Ltd
      • 12.3.1 Macleods Pharmaceutical Ltd Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Tuberculosis (TB) Treatment Introduction
      • 12.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.3.5 Macleods Pharmaceutical Ltd Recent Development
    • 12.4 Dong-A ST Co., Ltd
      • 12.4.1 Dong-A ST Co., Ltd Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Tuberculosis (TB) Treatment Introduction
      • 12.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.4.5 Dong-A ST Co., Ltd Recent Development
    • 12.5 Lupin Ltd
      • 12.5.1 Lupin Ltd Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Tuberculosis (TB) Treatment Introduction
      • 12.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.5.5 Lupin Ltd Recent Development
    • 12.6 Janssen Products, LP
      • 12.6.1 Janssen Products, LP Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Tuberculosis (TB) Treatment Introduction
      • 12.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.6.5 Janssen Products, LP Recent Development
    • 12.7 Mylan
      • 12.7.1 Mylan Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Tuberculosis (TB) Treatment Introduction
      • 12.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.7.5 Mylan Recent Development
    • 12.8 Sanofi
      • 12.8.1 Sanofi Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Tuberculosis (TB) Treatment Introduction
      • 12.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2014-2019)
      • 12.8.5 Sanofi Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Tuberculosis (TB) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis (TB) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Johnson & Johnson
      Otsuka Pharmaceutical Co., Ltd
      Macleods Pharmaceutical Ltd
      Dong-A ST Co., Ltd
      Lupin Ltd
      Janssen Products, LP
      Mylan
      Sanofi

      Market segment by Type, the product can be split into
      Isoniazid
      Rifampin (Rifadin, Rimactane)
      Ethambutol (Myambutol)
      Pyrazinamide

      Market segment by Application, split into
      Active TB
      Latent TB

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Tuberculosis (TB) Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Tuberculosis (TB) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Tuberculosis (TB) Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now